Related Experiment Video
Updated: Jun 16, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Intestinal protozoa infections among patients with ulcerative colitis: prevalence and impact on clinical disease
Jesús K Yamamoto-Furusho1, Emma Torijano-Carrera
1Inflammatory Bowel Disease Clinic, Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. kazuofurusho@hotmail.com
Background:
Epidemiological and microbiologic studies suggest that enteropathogenic microorganisms play a substantial role in the clinical initiation and relapses of inflammatory bowel disease.
Aim:
To explore the prevalence of intestinal protozoa in patients with ulcerative colitis (UC) and its impact on clinical disease course.
Methods:
A total of 215 patients with definitive diagnosis of UC were studied. Fresh feces samples taken from all UC patients were examined immediately using trichrome-staining methods.
Results:
A total of 103 female and 112 male UC patients were analyzed. The mean age at diagnosis was 30.5 +/- 10.8 years. The prevalence of overall parasitic infections was 24% and distributed as follows: Blastocystis hominis in 22 patients (10%), Endolimax nana in 19 cases (9%), and Entamoebahistolytica in 11 cases (5%). A significantly increased frequency of protozoa infection was found in those patients with persistent activity and intermittent activity as compared to active than inactive group (p = 1 x 10(-7), OR 13.05, 95% CI 4.28-42.56, and p = 0.003, OR 1.42-14.47, respectively). Interestingly, this association remained significant when we compared the persistent activity group versus intermittent activity group (p = 0.003, OR 2.97, 95% CI 1.35-6.59). Subgroup analysis showed no association between protozoa infection (E. histolytica, B. hominis, and E. nana) and other clinical variables such as gender, extent of disease, extraintestinal complications, medical treatment and grade of disease activity.
Conclusion:
The prevalence of intestinal protozoa infections in Mexican UC patients was 24% and these microorganisms could be a contributing cause of persistent activity despite medical treatment in our population.
Insights
Intestinal protozoa infections, including Blastocystis hominis and Entamoeba histolytica, were found in 24% of Mexican ulcerative colitis (UC) patients. These infections were linked to persistent disease activity, suggesting a role in UC relapses.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Microbiology
Background:
- Enteropathogenic microorganisms are implicated in the initiation and relapse of inflammatory bowel disease (IBD).
- Ulcerative colitis (UC) is a major form of IBD with complex etiologies.
Purpose of the Study:
- To determine the prevalence of intestinal protozoa in Mexican patients diagnosed with UC.
- To investigate the association between intestinal protozoa infections and the clinical course of UC.
Main Methods:
- A cohort of 215 patients with confirmed UC was studied.
- Fresh fecal samples were analyzed using trichrome staining for immediate examination.
- Protozoa identified included Blastocystis hominis, Endolimax nana, and Entamoeba histolytica.
Main Results:
- Overall protozoa infection prevalence was 24% in the UC cohort.
- Infections were significantly more frequent in patients with persistent and intermittent disease activity compared to inactive disease.
- Protozoa infection showed a significant association with persistent disease activity even when compared to intermittent activity.
Conclusions:
- The study identified a 24% prevalence of intestinal protozoa infections among Mexican UC patients.
- Intestinal protozoa may contribute to persistent UC activity, potentially impacting treatment outcomes in this population.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease IV: Clinical Manifestations
Giardiasis
Amebiasis
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease II: Ulcerative Colitis
